CCN1 and prostate adenocarcinoma: Similarly, in our study, by differential expression analysis from prostate adenocarcinoma TCGA database, we demonstrated that all the principal YAP transcriptional targets, CTGF, CYR61, BIRC5 and ANRDK1, were highly enriched in the patients with PCa tumors, compared with tumor free patients.